GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Predictive Oncology Inc (FRA:S1K) » Definitions » Shiller PE Ratio

Predictive Oncology (FRA:S1K) Shiller PE Ratio : (As of Jun. 25, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Predictive Oncology Shiller PE Ratio?

Note: If the price history is too short, we do not calculate current Shiller PE for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Predictive Oncology Shiller PE Ratio Historical Data

The historical data trend for Predictive Oncology's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Predictive Oncology Shiller PE Ratio Chart

Predictive Oncology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Predictive Oncology Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Predictive Oncology's Shiller PE Ratio

For the Medical Instruments & Supplies subindustry, Predictive Oncology's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Predictive Oncology's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Predictive Oncology's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Predictive Oncology's Shiller PE Ratio falls into.



Predictive Oncology Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Predictive Oncology's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Predictive Oncology's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0/131.7762*131.7762
=0.000

Current CPI (Mar. 2024) = 131.7762.

Predictive Oncology Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -2,150.945 100.560 -2,818.663
201409 -1,444.757 100.428 -1,895.736
201412 -3,104.102 99.070 -4,128.879
201503 -332.221 99.621 -439.453
201506 -1,595.353 100.684 -2,088.016
201509 -956.453 100.392 -1,255.462
201512 -1,995.622 99.792 -2,635.226
201603 -540.596 100.470 -709.042
201606 -169.100 101.688 -219.134
201609 -57.024 101.861 -73.771
201612 -30.438 101.863 -39.377
201703 -39.270 102.862 -50.309
201706 -72.980 103.349 -93.054
201709 -26.848 104.136 -33.974
201712 -27.040 104.011 -34.258
201803 -24.330 105.290 -30.450
201806 -34.240 106.317 -42.439
201809 -32.395 106.507 -40.081
201812 -42.544 105.998 -52.891
201903 -36.993 107.251 -45.452
201906 4.248 108.070 5.180
201909 -23.790 108.329 -28.939
201912 -81.720 108.420 -99.324
202003 -16.833 108.902 -20.369
202006 -6.394 108.767 -7.747
202009 -7.811 109.815 -9.373
202012 -9.521 109.897 -11.417
202103 -1.848 111.754 -2.179
202106 -0.830 114.631 -0.954
202109 -1.360 115.734 -1.549
202112 -2.301 117.630 -2.578
202203 -0.926 121.301 -1.006
202206 -2.734 125.017 -2.882
202209 -1.050 125.227 -1.105
202212 -1.935 125.222 -2.036
202303 -0.803 127.348 -0.831
202306 -0.905 128.729 -0.926
202309 -0.731 129.860 -0.742
202312 0.000 129.419 0.000
202403 0.000 131.776 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Predictive Oncology  (FRA:S1K) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Predictive Oncology Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Predictive Oncology's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Predictive Oncology (FRA:S1K) Business Description

Traded in Other Exchanges
Address
2915 Commers Drive, Suite 900, Eagan, MN, USA, 55121
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is included within corporate. The STREAMWAY System virtually eliminates staff exposure to blood, irrigation fluid, and other potentially infectious fluids found in the healthcare environment. Its Helomics division is focused on improving the effectiveness of cancer therapy using proprietary, multi-omic tumor profiling platform, a one-of-a-kind database of historical tumor data, and the power of AI to build predictive models of tumor drug response.

Predictive Oncology (FRA:S1K) Headlines

No Headlines